BACKGROUND: Chronic hemodialysis (HD) patients have an elevated risk of sudden cardiac death (SCD), particularly in the 24 hours before the first HD of the week. Temporal changes in cardiac autonomic dysfunction, as characterized by abnormalities in heart rate variability (HRV) and heart rate turbulence (HRT), along with T-wave alternans (TWA), may contribute to this dispersion of risk. OBJECTIVE: This study sought to determine the prevalence of abnormal HRV, HRT, and TWA in HD patients and to compare their temporal distribution among periods of variable SCD risk. METHODS: HRV, HRT, and TWA were analyzed from 72-hour Holter monitors in HD patients, and results were compared among the 24-hour high-risk period before the first dialysis session of the week, the 24-hour intermediate-risk period beginning with the weeks' first dialysis, and the low-risk period the day after the first dialysis. Positive cut points were standard deviation of all normal R-R intervals ≤70 ms for HRV, onset ≥0% and/or slope ≤2.5 ms/R-R for HRT, and ≥53 μV for TWA. RESULTS: Of 41 enrollees, 28 (46% male, age 55 ± 12, ejection fraction 57% ± 11%) had sufficient data for analysis. Abnormalities were prevalent with 82%, 75%, and 96% of patients reaching threshold for HRV, HRT, and TWA in at least one 24-hour period, respectively. There was no significant difference in the prevalence of abnormal measures among dialytic intervals nor in the intraindividual distribution of abnormal measures (P >.05 for all). CONCLUSION: Abnormal HRV, HRT, and TWA are prevalent in HD patients and may indicate heightened SCD risk. No significant correlation was observed among these measures and recognized periods of variable risk.
BACKGROUND: Chronic hemodialysis (HD) patients have an elevated risk of sudden cardiac death (SCD), particularly in the 24 hours before the first HD of the week. Temporal changes in cardiac autonomic dysfunction, as characterized by abnormalities in heart rate variability (HRV) and heart rate turbulence (HRT), along with T-wave alternans (TWA), may contribute to this dispersion of risk. OBJECTIVE: This study sought to determine the prevalence of abnormal HRV, HRT, and TWA in HDpatients and to compare their temporal distribution among periods of variable SCD risk. METHODS: HRV, HRT, and TWA were analyzed from 72-hour Holter monitors in HDpatients, and results were compared among the 24-hour high-risk period before the first dialysis session of the week, the 24-hour intermediate-risk period beginning with the weeks' first dialysis, and the low-risk period the day after the first dialysis. Positive cut points were standard deviation of all normal R-R intervals ≤70 ms for HRV, onset ≥0% and/or slope ≤2.5 ms/R-R for HRT, and ≥53 μV for TWA. RESULTS: Of 41 enrollees, 28 (46% male, age 55 ± 12, ejection fraction 57% ± 11%) had sufficient data for analysis. Abnormalities were prevalent with 82%, 75%, and 96% of patients reaching threshold for HRV, HRT, and TWA in at least one 24-hour period, respectively. There was no significant difference in the prevalence of abnormal measures among dialytic intervals nor in the intraindividual distribution of abnormal measures (P >.05 for all). CONCLUSION: Abnormal HRV, HRT, and TWA are prevalent in HDpatients and may indicate heightened SCD risk. No significant correlation was observed among these measures and recognized periods of variable risk.
Authors: Richard L Verrier; Thomas Klingenheben; Marek Malik; Nabil El-Sherif; Derek V Exner; Stefan H Hohnloser; Takanori Ikeda; Juan Pablo Martínez; Sanjiv M Narayan; Tuomo Nieminen; David S Rosenbaum Journal: J Am Coll Cardiol Date: 2011-09-20 Impact factor: 24.094
Authors: Rachel M Kaplan; Charles A Herzog; Brett Larive; Haris Subacius; Bruce D Nearing; Richard Verrier; Rod S Passman Journal: Ann Noninvasive Electrocardiol Date: 2016-03-28 Impact factor: 1.468
Authors: Beata Franczyk-Skóra; Anna Gluba-Brzózka; Jerzy Krzysztof Wranicz; Maciej Banach; Robert Olszewski; Jacek Rysz Journal: Int Urol Nephrol Date: 2015-05-12 Impact factor: 2.370
Authors: Hande Ozportakal; Abdullah Ozkok; Ozlem Alkan; Ahmet Sait Bulut; Memduha Boyraz; Mehmet Inanir; Goksel Acar; Ali Riza Odabas Journal: Int Urol Nephrol Date: 2016-12-10 Impact factor: 2.370
Authors: Syed Rizwan A Bokhari; Faisal Inayat; Ali Jawa; Hafeez Ul Hasan Virk; Muhammad Awais; Nadeem Hussain; Ghias Ul Hassan; Hafiz Ijaz Ahmad; Hammad S Chaudhry; Abdullah Adil; Ali Haider; Vincent M Figueredo; Janani Rangaswami; Muhammad Zaman Khan Assir Journal: Cureus Date: 2018-08-31
Authors: Nichole M Rogovoy; Stacey J Howell; Tiffany L Lee; Christopher Hamilton; Erick A Perez-Alday; Muammar M Kabir; Yanwei Zhang; Esther D Kim; Jessica Fitzpatrick; Jose M Monroy-Trujillo; Michelle M Estrella; Stephen M Sozio; Bernard G Jaar; Rulan S Parekh; Larisa G Tereshchenko Journal: J Am Heart Assoc Date: 2019-09-28 Impact factor: 5.501
Authors: Márcio Galindo Kiuchi; Jan K Ho; Janis Marc Nolde; Leslie Marisol Lugo Gavidia; Revathy Carnagarin; Vance B Matthews; Markus P Schlaich Journal: Front Physiol Date: 2020-01-14 Impact factor: 4.566
Authors: Tao Song; Xiu Fen Qu; Ying Tao Zhang; Wei Cao; Bai He Han; Yang Li; Jing Yan Piao; Lei Lei Yin; Heng Da Cheng Journal: BMC Cardiovasc Disord Date: 2014-05-01 Impact factor: 2.298